U.S. Senator Cory Booker says he was stunned by the revelation that Republican U.S. Senate candidate Bob Hugin sold a cancer drug in Russia for about the half the price in the United States.
“To me, I think it’s a mortal blow,” Booker told the New Jersey Globe on Monday after a campaign stop in Parsippany.
Booker says independent polling he’s seen show that one of the biggest issues in New Jersey is the high cost of prescription drugs.
“People are having to take live saving drugs and make tough financial choices over whether to make mortgage payments, rental payments and the like,” Booker said. “So here is a guy who was in charge of a company that lowered drug prices for Russians but would not do it for people in the United States of America.”
Booker said that voters have a choice between “a drug company executive who was driving up prices, or an incumbent Senator who is in a position to fight to fight to drive prices down.”
The story that Celgene, the pharmaceutical company Hugin ran, cut the price of Revlimid, an expensive life-saving cancer drug in Russia by about 45% while raising the cost in the United States by 20% first appeared on NJ.com on Sunday.